Sorbent/ion exchange resin column for pigment removal in recycled TPU

Technology
In development
Company

A novel sorbent/ion exchange resin column designed to efficiently remove pigments from recycled thermoplastic polyurethane (TPU) during the glycolysis process, enhancing the quality of recovered polyols for new PU production.

Overview

The sorbent/ion exchange resin-packed column offers a groundbreaking solution for pigment removal in the recycling of thermoplastic polyurethane (TPU). By integrating this column into the glycolysis process, the system efficiently depolymerizes TPU, recovering high-quality polyols and glycolysates while removing unwanted pigments. This innovation not only enhances the recyclability of TPU but also supports the production of new polyurethane materials from recycled components.

Technical specifications

Key features:

  • Utilizes a glycolysis process with sodium/potassium acetate catalysts to break down TPU into polyols and glycolysates.
  • Operates effectively at temperatures between 200-220°C under atmospheric pressure.
  • Incorporates a sorbent/ion exchange resin column with customizable functional groups for optimal pigment filtration.
  • Allows optimization of parameters such as catalyst dosage, temperature, contact time, and resin packing density.
  • Supports reusability of glycols through distillation and conversion of by-products into high-value materials.
Technology readiness level

This technology has been validated at a laboratory scale, with a Technology Readiness Level of 4. Future studies aim to optimize reaction conditions, sorbent materials, and operational parameters to enhance scalability and efficiency.


About SIBCo Medical and Pharmaceuticals Sdn. Bhd.

SIBCo Medical and Pharmaceuticals Sdn. Bhd. is a Malaysia-incorporated division of the broader SIBCo Group, a conglomerate focused on Islamic economy and investment activities. The medical division is led by professionals with extensive experience in government, private, and NGO healthcare sectors. It is dedicated to participating in the medical and pharmaceutical industries as part of the group's wider efforts to structure investments and foster collaborative ventures across various sectors, including energy, infrastructure, and agriculture.

By leveraging the expertise of its leadership team, the company operates within a framework that emphasizes Shariah compliance and sustainable economic development. The medical unit serves as a critical component of the group's interest in sectors aligned with growing global demand, including nutraceuticals and general healthcare. Through this divisional approach, the company engages in planning and development activities intended to build trust with partners and counterparts while contributing to the group's diversified international business interests.

Sign up to access the full partnering listing.
View the details of this partnering listing and connect directly with the teams behind promising technologies.
Halo home
Partner smarter. Move faster.
Get new partnering requests
delivered to your inbox.